- Home
- MS vs NVS Comparison
MS vs NVS Comparison
Compare MS & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MS
- NVS
- Stock Information
- Founded
- MS 1924
- NVS 1895
- Country
- MS United States
- NVS Switzerland
- Employees
- MS N/A
- NVS N/A
- Industry
- MS Investment Bankers/Brokers/Service
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- MS Finance
- NVS Health Care
- Exchange
- MS Nasdaq
- NVS Nasdaq
- Market Cap
- MS 202.7B
- NVS 230.5B
- IPO Year
- MS N/A
- NVS 1991
- Fundamental
- Price
- MS $131.69
- NVS $109.37
- Analyst Decision
- MS Buy
- NVS Hold
- Analyst Count
- MS 16
- NVS 6
- Target Price
- MS $134.29
- NVS $123.67
- AVG Volume (30 Days)
- MS 5.3M
- NVS 2.1M
- Earning Date
- MS 04-11-2025
- NVS 01-31-2025
- Dividend Yield
- MS 2.81%
- NVS 3.44%
- EPS Growth
- MS 53.47
- NVS N/A
- EPS
- MS 7.95
- NVS 5.87
- Revenue
- MS $61,497,000,000.00
- NVS $51,722,000,000.00
- Revenue This Year
- MS $10.92
- NVS $3.52
- Revenue Next Year
- MS $5.85
- NVS $2.10
- P/E Ratio
- MS $16.56
- NVS $18.05
- Revenue Growth
- MS 14.71
- NVS 10.85
- 52 Week Low
- MS $84.43
- NVS $92.35
- 52 Week High
- MS $142.03
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- MS 41.00
- NVS 64.90
- Support Level
- MS $135.44
- NVS $106.10
- Resistance Level
- MS $141.07
- NVS $108.09
- Average True Range (ATR)
- MS 3.07
- NVS 1.39
- MACD
- MS -0.93
- NVS 0.06
- Stochastic Oscillator
- MS 7.01
- NVS 88.19
About MS Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.